Cargando…
Cholinergic Receptor Modulation as a Target for Preventing Dementia in Parkinson’s Disease
Parkinson’s disease (PD) is a neurodegenerative condition characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc) in the midbrain resulting in progressive impairment in cognitive and motor abilities. The physiological and molecular mechanisms triggering dopamin...
Autores principales: | Iarkov, Alexandre, Mendoza, Cristhian, Echeverria, Valentina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488354/ https://www.ncbi.nlm.nih.gov/pubmed/34616271 http://dx.doi.org/10.3389/fnins.2021.665820 |
Ejemplares similares
-
Nicotinic acetylcholine receptors and learning and memory deficits in Neuroinflammatory diseases
por: Echeverria, Valentina, et al.
Publicado: (2023) -
Strategies for the Treatment of Parkinson’s Disease: Beyond Dopamine
por: Iarkov, Alexandre, et al.
Publicado: (2020) -
Beneficial effects of nicotine, cotinine and its metabolites as potential agents for Parkinson’s disease
por: Barreto, George E., et al.
Publicado: (2015) -
Cotinine Plus Krill Oil Decreased Depressive Behavior, and Increased Astrocytes Survival in the Hippocampus of Mice Subjected to Restraint Stress
por: Mendoza, Cristhian, et al.
Publicado: (2018) -
Cholinergic and perfusion brain networks in Parkinson disease dementia
por: Colloby, Sean J., et al.
Publicado: (2016)